Inactive Instrument

All News KaloBios Pharmaceuticals Inc Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

May. 01	Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc.	CI
Apr. 12	Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.	CI

Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc.	May. 01	CI
Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.	Apr. 12	CI
Final DIP Financing Approved for Humanigen, Inc.	Mar. 07	CI
Motion for Asset Sale Approved for Humanigen, Inc.	Feb. 16	CI
Notice for Auction Cancellation Filed by Humanigen, Inc.	Feb. 12	CI
Bidding Procedure Approved for Humanigen, Inc.	Jan. 24	CI
19 treatment developer Humanigen files for Chapter 11 bankruptcy	Jan. 04	RE
Motion for Asset Sale Filed by Humanigen, Inc.	Jan. 03	CI
Humanigen, Inc. Filed for Bankruptcy	Jan. 03	CI
Interim DIP Financing Approved for Humanigen, Inc.	Jan. 02	CI
Xspray Pharma Names Chief Commercial Officer	23-09-15	MT
Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer	23-09-14	CI
North American Morning Briefing : PCE Inflation -2-	23-08-31	DJ
North American Morning Briefing : Nasdaq Futures -2-	23-08-24	DJ
CapitalGainesReport: OTC Bounce List (EPAZ, ABML, HGEN, RINO)	23-08-09	AQ
Humanigen, Inc.(OTCPK:HGEN) dropped from S&P TMI Index	23-07-28	CI
Sector Update: Health Care Stocks Steady in Late Afternoon Trading	23-07-25	MT
Sector Update: Health Care Stocks Steady Tuesday Afternoon	23-07-25	MT
Sector Update: Health Care	23-07-25	MT
Humanigen Issues 'Going Concern' Warning; Shares Hit 52-Week Low	23-07-25	MT

No results for this search